期刊文献+

优福定脂质体的处方与工艺优化 被引量:6

Optimization of Formula and Preparation Technique of UFT Liposomes
原文传递
导出
摘要 目的:优化优福定脂质体的处方和制备工艺。方法:采用薄膜分散-冷冻干燥法制备优福定脂质体,以主药替加氟和尿嘧啶包封率为指标,应用正交试验优化其处方和制备工艺;考察其体外释放度并与普通片剂进行比较。结果:所得优化处方为磷脂与药物的重量比16∶1,磷脂与胆固醇的重量比7∶1,pH5.6的磷酸盐缓冲液为水合递质,水化温度为40℃。在此条件下,替加氟和尿嘧啶的平均包封率分别为(46.6±2.01)%、(48.7±1.49)%;脂质体的体外释放符合一级动力学方程,具有缓释作用。结论:优化得到的优福定脂质体处方工艺简便,稳定。 OBJECTIVE: To optimize the formula and preparation technique of UFT (tegafur/uracil) liposomes. METHODS: The liposomes were prepared by the film hydration- freeze drying technique; and the entrapment efficiencies of UFT (tegafur/uracil) liposomes were taken as parameters, the formula and preparation technique of the liposomes were optimized by orthogonal design; the in vitro drug release behavior of liposome was compared with that of the common market tablet. RESULTS: The optimum formula were as follows: the ratio between drugs and Lecithin was 16 : 1; lecithin : choles- terol = 7 : 1; pH of PBS was 5.6, the temperature of the hydration was 401Z . Under this condition, the average entrapment efficiency for tegafur was (46.6± 2.01) % and that for uracil was (48.7±1.49) %. The release rule in vitro of liposome was in conformity with the first order kinetic equation, and the release behaviors of liposome has slow-release. CONCLUSION: The preparation technique for UFT liposomes is simple and stable.
作者 宋力 范文源
出处 《中国药房》 CAS CSCD 北大核心 2007年第19期1479-1481,共3页 China Pharmacy
关键词 优福定 脂质体 处方 工艺优化 正交设计 UFT Liposomes Formula Preparation Orthogonal design
  • 引文网络
  • 相关文献

参考文献7

  • 1Sato Y,Inaba Y,Yamaura H,et al.Retrospective analysis of tegafur/uracil (UFT) plus oral leucovorin(LV) regimen in patients with advanced colorectal cancer[J].Gan To Kagaku Ryoho,2006,33(7):887. 被引量:1
  • 2Shibaki T,Morimoto N.Advanced rectal cancer in an older patient,in whom metastatic liver lesions were effectively controlled with oral UFT + LV and venous CPT-11 administration-case report[J].Gan To Kagaku Ryoho,2006,33(6):825. 被引量:1
  • 3Chen YM,Perng RP,Tsai CM,et al.A phase Ⅱ trial of gemcitabine plus UFUR combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy[J].Lung Cancer,2006,52(3):333. 被引量:1
  • 4Ohwada S,Ogawa T,Makita F,et al.Beneficial effects of protein-bound polysaccharide K plus tegafur/uracil in patients with stage Ⅱ or Ⅲ colorectal cancer:analysis of immunological parameters[J].Oncol Rep,2006,15(4):861. 被引量:1
  • 5倪永兴.药学应用数理统计[M].北京:军事谊文出版社,1994.131. 被引量:8
  • 6陈礼明,刘圣,唐丽琴,李矗.正交试验优选黄连散中葛根等成分的提取工艺[J].中国药房,2006,17(6):415-417. 被引量:12
  • 7国家药典委员会编..中华人民共和国药典 2005年版 一部[M].北京:化学工业出版社,2005:668.

二级参考文献7

共引文献18

同被引文献36

引证文献6

二级引证文献25

;
使用帮助 返回顶部